access+affordability

Josh Wilkerson switched to a cheaper insulin when the price of his life-saving medication went up, a decision that ended up being fatal.

Hundreds of cystic fibrosis sufferers in Scotland will have access drugs that can help extend their life after a deal was struck on costs.

Malaria, which kills one child globally every two minutes, is the top killer of children under five in the east African country.

People living with diabetes will hold a vigil at the headquarters of Eli Lilly to protest the high price of insulin.

Across the country, low-income patients are overcoming stigmas surrounding poverty to speak out about nonprofit hospitals that sue them. Federal officials are noticing. Help us keep the pressure on.

The move comes one month after the Scottish Medicines Consortium had recommended the National Health Service in Scotland should not cover the Orkambi and Symkevi medicines.

A five year pricing agreement to supply NHS Scotland with medicines to benefit patients living with cystic fibrosis in Scotland has been secured following discussions between Vertex Pharmaceuticals and the Scottish Government.

Medicaid, the U.S. government program that provides health care to more than 75 million low-income and disabled Americans, isn’t necessarily free. It’s the only major welfare program that can function like a loan.

The number of UK-born people living in the EU - workers and their dependants, pensioners, students and others - is estimated at 1.3 million.

In France, a visit to the doctor typically costs the equivalent of $1.12. A night in a German hospital costs a patient roughly $11.

Today, three companies control virtually the entire global market for insulin.

Dave Roberts is fighting for his life, and his doctor says there is only one option left to him, an immunotherapy treatment called Kymriah.

Number of Americans without insurance shows first increase since 2008

Glybera was a made-in-Canada medical breakthrough that became the world's most-expensive drug.

Rebekah Gee says bipartisanship and bringing in the federal government early in the process, via CMS in an advisory role, was crucial to successfully navigating this drug pricing deal.